Come up with a name for your new list and we'll add to it:
Profectus BioSciences raised a round of funding on May 15, 2006. Investors include
Cross Atlantic Capital Partners.
Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, mean…